<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">633403</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.633403</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Novel Role of A<sub>2A</sub>R in the Maintenance of Intestinal Barrier Function of Enteric Glia from Hypoxia-Induced Injury by Combining&#x20;with mGluR5</article-title>
<alt-title alt-title-type="left-running-head">Sun et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">A<sub>2A</sub>R in Intestinal Barrier</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Lihua</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/571955/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xiang</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guan</surname>
<given-names>Haidi</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Shuaishuai</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Xin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Chao</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/771029/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Hua</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiao</surname>
<given-names>Weidong</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff>Department of General Surgery, Xinqiao Hospital, Army Medical University, <addr-line>Chongqing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/143688/overview">Thomas Brzozowski</ext-link>, Jagiellonian University Medical College, Poland</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1189196/overview">Carmen Diniz</ext-link>, University of Porto, Portugal</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/144517/overview">Geetha Samak</ext-link>, DVS College of Arts and Science, India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Weidong Xiao, <email>weidong.xiao@126.com</email>; Hua Yang, <email>hwbyang@126.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work.</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>05</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>633403</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>12</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>03</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Sun, Li, Guan, Chen, Fan, Zhou, Yang and Xiao.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Sun, Li, Guan, Chen, Fan, Zhou, Yang and Xiao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>During acute intestinal ischemia reperfusion (IR) injury, the intestinal epithelial barrier (IEB) function is often disrupted. Enteric glial cells (EGCs) play an important role in maintaining the integrity of IEB functions. However, how EGCs regulate IEB function under IR stimulation is unknown. The present study reveals that the adenosine A<sub>2A</sub> receptor (A<sub>2A</sub>R) is important for mediating the barrier-modulating roles of EGCs. A<sub>2A</sub>R knockout (KO) experiments revealed more serious intestinal injury in A<sub>2A</sub>R KO mice than in WT mice after IR stimulation. Moreover, A<sub>2A</sub>R expression was significantly increased in WT mice when challenged by IR. To further investigate the role of A<sub>2A</sub>R in IEB, we established an <italic>in&#x20;vitro</italic> EGC-Caco-2&#x20;co-culture system. Hypoxia stimulation was used to mimic the process of <italic>in vivo</italic> IR. Treating EGCs with the CGS21680 A<sub>2A</sub>R agonist attenuated hypoxia-induced intestinal epithelium damage through up-regulating ZO-1 and occludin expression in cocultured Caco-2 monolayers. Furthermore, we showed that A<sub>2A</sub>R and metabotropic glutamate receptor 5 (mGluR5) combine to activate the PKC&#x3b1;-dependent pathway in conditions of hypoxia. This study shows, for the first time, that hypoxia induces A<sub>2A</sub>R-mGluR5 interaction in EGCs to protect IEB function via the PKC&#x3b1; pathway.</p>
</abstract>
<kwd-group>
<kwd>A<sub>2A</sub>R</kwd>
<kwd>intestinal epithelial barrier</kwd>
<kwd>mGluR5</kwd>
<kwd>enteric glial cells</kwd>
<kwd>hypoxia</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Ischemia-reperfusion (IR) injury of the intestine is a fatal syndrome in abdominal surgeries involving aortic aneurysm, small bowel or liver transplantation, cardiopulmonary bypass, strangulated hernias, and neonatal necrotizing entero colitis (<xref ref-type="bibr" rid="B25">Mallick et&#x20;al., 2004</xref>). Acute intestinal IR injury is one of the most important causes of disruption to the intestinal epithelial barrier (IEB), initiates the systemic inflammatory response syndrome, and leads to multiple organ disorders (<xref ref-type="bibr" rid="B38">Vollmar and Menger, 2011</xref>; <xref ref-type="bibr" rid="B24">Lu et&#x20;al., 2012</xref>). For these reasons, increasing attention has been focused on the underlying mechanisms of intestinal IR and promising protective strategies.</p>
<p>Traditionally, enteric glial cells (EGCs), the most abundant cell type in the intestinal nervous system, have been proposed to provide trophic and supportive effects for enteric neurons (<xref ref-type="bibr" rid="B3">Aube et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B32">Ruhl, 2005</xref>). However, accumulating evidence reveals that EGCs also play an important role in the regulation of intestinal epithelial proliferation and the intestinal mucosal defense system (<xref ref-type="bibr" rid="B30">Neunlist et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B7">Cheadle et&#x20;al., 2013</xref>). EGCs are responsible for enhanced gut permeability and barrier dysfunction in inflammatory bowel disease (IBD) (<xref ref-type="bibr" rid="B45">Zhang et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B6">Cabarrocas et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B39">von Boyen and Steinkamp, 2010</xref>; <xref ref-type="bibr" rid="B29">Neunlist et&#x20;al., 2008</xref>). In transgenic mice, the conditional deletion of EGCs results in the development of fulminant intestinal inflammation with mucosal barrier breakdown (<xref ref-type="bibr" rid="B5">Bush et&#x20;al., 1998</xref>). Previously, we demonstrated that EGCs enhance IEB functions in response to lipopolysaccharide (LPS) stimulation by inhibiting increased iNOS activity (<xref ref-type="bibr" rid="B42">Xiao et&#x20;al., 2011</xref>). We also found that EGC-released glial-derived neurotrophic factor (GDNF) is closely involved in the IEB protective mechanisms of EGCs in acute IR stimulation (<xref ref-type="bibr" rid="B43">Xiao et&#x20;al., 2014</xref>). However, the precise mechanisms by which EGCs regulate IEB in IR injury have not been elucidated.</p>
<p>The Adenosine A<sub>2A</sub> receptor (A<sub>2A</sub>R), one of four G protein&#x2013;coupled adenosine receptors (including A<sub>1</sub>R, A<sub>2A</sub>R, A<sub>2B</sub>R, and A<sub>3</sub>R), binds adenosine and induces activation of adenylate cyclase, promoting cAMP synthesis and producing corresponding biological effects (<xref ref-type="bibr" rid="B41">Welihinda et&#x20;al., 2016</xref>). A<sub>2A</sub>R is involved in the regulation of several physiological functions, including in the gastrointestinal system (<xref ref-type="bibr" rid="B14">Fornai et&#x20;al., 2009</xref>). A<sub>2A</sub>R has diverse and important roles in the intestine, including gut motor functions, acetylcholine release, cholinergic contraction modulation, and enteric nervous system regulation (<xref ref-type="bibr" rid="B11">Duarte-Ara&#xfa;jo et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B2">Antonioli et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B14">Fornai et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B34">Schriemer et&#x20;al., 2016</xref>). DucoSchriemer et&#x20;al. revealed that A<sub>2A</sub>R is a key regulator of terminal neuronal differentiation in GDNF-treated enteric neural crest cells (ENCCs) (<xref ref-type="bibr" rid="B34">Schriemer et&#x20;al., 2016</xref>). However, there is relatively little information about the role of A<sub>2A</sub>R in EGCs. Therefore, this study was designed to investigate the role of A<sub>2A</sub>R in EGC-mediated IEB regulation.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Cell Culture and Co-Culture</title>
<p>Rat EGC/PK060399egfr (CRL-2690&#x2122;) and human intestinal epithelial cells Caco-2 (HTB-37&#x2122;) were obtained from the American Type Culture Collection. EGC/PK060399egfr and Caco-2 cells were grown in high glucose DMEM and MEM, respectively, supplemented with 10% FCS, 2&#xa0;mM <sc>l</sc>-glutamine, and 100&#xa0;U/100&#xa0;&#x3bc;g/ml penicillin&#x2013;streptomycin. Cells were incubated in a 5% CO<sub>2</sub> humidified incubator at 37&#xb0;C. The EGC-Caco-2&#x20;co-culture system was established as described previously by our laboratory (<xref ref-type="bibr" rid="B43">Xiao et&#x20;al., 2014</xref>). Caco-2 cells were seeded on Millicell&#xae;filters (0.4&#xa0;&#x3bc;m pore diameter; Millipore; Billerica, MA) at a density of 5&#x20;&#xd7; 10<sup>4</sup>&#xa0;cells/cm<sup>2</sup> for up to 4&#x2013;5&#xa0;days. EGCs were seeded at an equal density in 6 or 24 well tissue culture plates to avoid any possible direct cell contact with Caco-2 cells. During the co-culture period, half of the culture medium in the apical and basal compartments was changed&#x20;daily.</p>
</sec>
<sec id="s2-2">
<title>Mice</title>
<p>Global A<sub>2A</sub>R homozygous KO mice (A<sub>2A</sub>R<sup>&#x2212;/&#x2212;</sup> mice) with C57BL/6J background were provided by Dr. Yuanguo Zhou (Research Institute of Surgery, Daping Hospital, Army Medical University, Chongqing, China). Specific pathogen-free wild-type (WT) C57BL/6J mice were purchased from the Laboratory Animal Center of the Army Medical University. All mice were housed and maintained in laminar flow cabinets under specific pathogen-free conditions.</p>
</sec>
<sec id="s2-3">
<title>In Vitro Hypoxia Experiments</title>
<p>For hypoxia experiments, cells were subjected to hypoxia in a CO<sub>2</sub> incubator (Forma&#xae; Series II Water Jacketed CO<sub>2</sub> Incubators; Thermo Scientific) with 94% nitrogen, 5% CO<sub>2</sub>, and 1% oxygen and incubated at 37&#xb0;C for 6&#xa0;h. Re-oxygenation was initiated by replacing the media and exposing the cell monolayers to 37&#xb0;C plus 5% CO<sub>2</sub>for 1&#xa0;h. Control cells were maintained at 37&#xb0;C in an atmosphere with 5%&#x20;CO<sub>2</sub>.</p>
</sec>
<sec id="s2-4">
<title>Intestinal Ischemia/Reperfusion Model</title>
<p>Male mice (8&#x2013;10&#xa0;weeks old) were fasted for 12&#xa0;h and were free to drink water prior to surgery. The animals were intraperitoneally injected with 40&#xa0;mg/kg of pentobarbital anesthesia and an aseptic laparotomies dioventral line was placed. The following specific surgical procedures were performed as previously described (<xref ref-type="bibr" rid="B43">Xiao et&#x20;al., 2014</xref>).</p>
</sec>
<sec id="s2-5">
<title>Western Blot Analysis</title>
<p>Cells and tissues were lyzed in cold RIPA buffer for 30&#xa0;min and centrifuged at 13,000&#xd7; <italic>g</italic> for 30&#xa0;min at 4&#xb0;C. Protein concentration was determined using a BCA assay reagent (Beyotime). The primary antibodies used were rabbit anti-ZO-1 (1:800), rabbit anti-Occludin (1:1000), mouse anti-A<sub>2A</sub>R (1:500), rabbit anti-PKC&#x3b1; (1:1000), rabbit anti-Na&#x2b;/K&#x2b; ATPase (1:1000), and rabbit anti-GAPDH (1:1,000). Protein expression was measured in optical density units and normalized to GAPDH expression.</p>
</sec>
<sec id="s2-6">
<title>Immunofluorescence Staining</title>
<p>The small intestine tissues were embedded with OCT compound (Tissue-Tek, Sakura Finetek, Torrance, CA, United&#x20;States). Consecutive frozen sections (5&#xa0;&#x3bc;m in thickness) were obtained and fixed in 4% paraformaldehyde for 20&#xa0;min at room temperature. After 30&#xa0;min pre-incubation with a blocking solution containing 5% bovine serum albumin, sections were incubated overnight at 4&#xb0;C with primary antibody against GFAP (Abcam), A<sub>2A</sub>R (Abcam), or ZO-1 (Abcam). After washing in PBS, sections were incubated with fluorescence-conjugated secondary antibodies at 37&#xb0;C for 1&#xa0;h. After washing in PBS, sections were incubated with DAPI nuclear stain solution for 5&#xa0;min. All images were obtained using a TCS-SP5 confocal microscope (Leica, Germany).</p>
</sec>
<sec id="s2-7">
<title>Coimmunoprecipitation</title>
<p>Cells were harvested and lyzed in standard immunoprecipitation (IP) buffer containing either 1% 3-[(3-cholamidopropyl) dimethylammonio] propanesulfonic acid (Chaps) or 1% Triton X-100 (for ERAD substrates), or 2% digitonin (for ERAD machinery) for 1&#xa0;h on ice. Cells were centrifuged at 16,000 &#xd7; <italic>g</italic> for 10&#xa0;min, and the supernatant was used for immunoprecipitation experiments. Co-IP was performed using protein A-agarose beads (EMD Millipore) with anti-A<sub>2A</sub>R (Santa Cruz Biotechnology, Inc.), anti-mGluR5 antibodies (Cell signaling), or anti-D2R antibodies (Santa Cruz Biotechnology, Inc.) following the usual method.</p>
</sec>
<sec id="s2-8">
<title>Transepithelial Electrical Resistance (TER) and Permeability Measurements</title>
<p>The TER of cells was determined via a Millipore electric resistance system (ERS-2; Millipore). Caco-2 cell monolayers were grown in Millicell inserts (0.33&#xa0;cm<sup>2</sup> area, 0.4&#xa0;&#x3bc;m pore diameter, and 6.5&#xa0;mm diameter) and the culture medium was replaced before TER measurement. To calculate the actual resistance of the cell monolayer, the mean resistance of filters without cells was subtracted from the monolayer measurement, and the difference between the filter and monolayer areas was corrected.</p>
<p>The intestinal mucosa TER was measured by Ussing chambers (Physiologic Instruments, San Diego, CA). The excised intestinal tissues were bathed in 5&#xa0;ml Krebs buffer (110.0&#xa0;mM NaCl, 3.0&#xa0;mMCaCl<sub>2</sub>, 5.5&#xa0;mM KCl, 1.4&#xa0;mM KH<sub>2</sub>PO<sub>4</sub>, 29.0&#xa0;mM NaHCO<sub>3</sub>, and 1.2&#xa0;mM MgCl<sub>2</sub>, pH 7.4)on both the mucosal and serosal sides. The TER was measured as previously described (<xref ref-type="bibr" rid="B23">Liu et&#x20;al., 2018</xref>).</p>
</sec>
<sec id="s2-9">
<title>Statistical Analysis</title>
<p>All experimental data are shown as the Mean&#x20;&#xb1; SD. Statistical significance was determined by unpaired two-tailed Student <italic>t</italic>&#x20;test analysis using GraphPad Prism version 7.0 software (San Diego, CA). If not otherwise stated, all experiments included three independent replications in triplicate. <italic>p</italic>&#x20;&#x3c; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Acute IR Treatment Significantly Activated A<sub>2A</sub>R Expression in Intestinal Mucosa EGC</title>
<p>To study the effect of A<sub>2A</sub>R on EGC, we first examined the expression of A<sub>2A</sub>R in different pathological conditions. Lipopolysaccharide (LPS) and hypoxia treatments were used to stimulate EGCs <italic>in&#x20;vitro</italic>. As shown in <xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>, A<sub>2A</sub>R expression dramatically increased in EGCs following LPS and hypoxia stimulation, with the effect of hypoxia being obvious than that of LPS. Therefore, hypoxia treatment was used to study the effect of A<sub>2A</sub>R. As demonstrated previously, GFAP is a specific marker of activated glial cells (<xref ref-type="bibr" rid="B43">Xiao et&#x20;al., 2014</xref>). A<sub>2A</sub>R and GFAP immunofluorescent staining colocalization were used to observe changes in A<sub>2A</sub>R expression in EGCs. Acute IR-treated mice showed a moderate decrease in GFAP-positive intestinal EGCs compared to sham-treated mice (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). However, the A<sub>2A</sub>R levels increased significantly in GFAP-positive EGCs after IR treatment. Together, these results indicate that hypoxia stimulation can activate the A<sub>2A</sub>R-mediated signaling pathway in mucosal EGCs in the intestine.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Expression of A<sub>2A</sub>R in enteric glial cells (EGCs) under hypoxia stimulation. <bold>(A)</bold> Western blot analysis shows a significant increase of A<sub>2A</sub>R protein level in cultured EGC cells after hypoxia and reoxygenation treatment. GAPDH was used as a standard for cellular protein input. <bold>(B)</bold> Immunofluorescence was used to detect A<sub>2A</sub>R expression in the small intestine under IR treatment. Red and green signals represent GFAP and A<sub>2A</sub>R, respectively. Results are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 4&#x2013;6 mice/group) (&#x2a;<italic>p</italic>&#x20;&#x3c; 0.05).</p>
</caption>
<graphic xlink:href="fphar-12-633403-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Activation of A<sub>2A</sub>R in EGCs Efficiently Prevents Barrier Dysfunction of Caco-2 Monolayers Under Hypoxia Stimulation</title>
<p>To further explore the role of A<sub>2A</sub>R in IEB modulation under acute hypoxia stimulation, we used an A<sub>2A</sub>R agonist and inhibitor separately in an <italic>in&#x20;vitro</italic> EGC-Caco-2&#x20;co-culture system. The tight junctions (TJs) are primary determinants of IEB function (<xref ref-type="bibr" rid="B20">Lee, 2015</xref>). As shown in <xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>, western blot analysis revealed an almost 50% drop in ZO-1 and occludin expression in the hypoxia group and a similar reduction on ZO-1 and occludin expression in the A<sub>2A</sub>R inhibitor ZM241385 group. However, the A<sub>2A</sub>R agonist CGS21680 significantly prevented hypoxia-induced TJs destruction. Further study with immunocytochemistry (ICC) confirmed the western blot results (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>). Additionally, TER measurement analysis produced similar results. CGS21680 pretreatment effectively blocked TER decrease under hypoxia stimulation when compared to the ZM241385 pretreatment group (528.6&#x20;&#xb1; 18.11&#xa0;&#x3a9;&#xa0;cm<sup>2</sup> vs. 289.6&#x20;&#xb1; 12.63&#xa0;&#x3a9;&#xa0;cm<sup>2</sup> for the CGS21680 and ZM241385 pretreatment groups, respectively) (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). Together, these results showed that A<sub>2A</sub>R plays a protective role in the EGC barrier-protecting effect on the IEC monolayer under hypoxia stimulation.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Activation of A<sub>2A</sub>R in enteric glial cells (EGCs) prevents Caco-2 monolayer barrier dysfunction under hypoxia stimulation. <bold>(A&#x2013;C)</bold> EGCs were co-cultured with Caco-2 monolayers for 24&#xa0;h and then treated with ZM241385 (1&#xa0;&#x3bc;M) and CGS21680 (100&#xa0;nM) for 6&#xa0;h respectively under hypoxia conditions. <bold>(A)</bold> Western blot and <bold>(B)</bold> immunofluorescence analyses were used to detect ZO-1 and occludin expression. <bold>(C)</bold> The transepithelial electrical resistance (TER) of Caco-2 monolayers was determined to evaluate intestinal epithelial barrier (IEB) function. Results are expressed as mean&#x20;&#xb1; SD. (&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01; &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001; &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.0001; NS, not significant.)</p>
</caption>
<graphic xlink:href="fphar-12-633403-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>A<sub>2A</sub>R Deficiency Aggravates IR-Induced IEB Injury</title>
<p>To further confirm the role of A<sub>2A</sub>R in the barrier protective of EGCs during hypoxia stimulation, A<sub>2A</sub>R KO mice were treated with IR. Western blot analysis of ZO-1 and occludin expression was assessed in the small intestine (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Acute IR treatment led to a substantial decrease in ZO-1 and occludin expression in A<sub>2A</sub>R KO mice compared to WT mice. Immunofluorescence analysis also revealed a similar reduction in ZO-1 and occludin expression in the intestinal mucosa after IR stimulation (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). The functional impact of A<sub>2A</sub>R knockdown on tight junctions in the small intestine was further evaluated by determining the TER value using Ussing chambers. As shown in <xref ref-type="fig" rid="F3">Figure&#x20;3E</xref>, intestinal I/R caused a marked TER decrease in A<sub>2A</sub>R KO mice (78.63&#x20;&#xb1; 3.407&#xa0;&#x3a9;&#xa0;cm<sup>2</sup>) compared with WT mice (94.5&#x20;&#xb1; 3.151&#xa0;&#x3a9;&#xa0;cm<sup>2</sup>). Histological examination of intestinal tissues revealed that IR-treated A<sub>2A</sub>R KO mice showed more increased intestinal villus fracturing and epithelial removal than did WT mice (<xref ref-type="fig" rid="F3">Figures 3C</xref>,<xref ref-type="fig" rid="F3">D</xref>). Together, these results strongly suggest that A<sub>2A</sub>R has a significant protective effect in IR-induced IEB injury.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>A<sub>2A</sub>R deficiency aggravates IR-induced intestinal epithelial barrier (IEB) injury. IEB function was assessed in IR-treated WT and A<sub>2A</sub>R<sup>&#x2212;/&#x2212;</sup> mice by <bold>(A)</bold> ZO-1 and occludin protein expression measured by western blot <bold>(B)</bold>, ZO-1 and occludin protein expression measured by immunofluorescence, and <bold>(E)</bold> the small intestine TER value. The degree of intestinal damage was assessed in IR-treated WT and A<sub>2A</sub>R<sup>&#x2212;/&#x2212;</sup> mice by <bold>(C)</bold> hematoxylin and eosin staining, and <bold>(D)</bold> Chiu&#x2019;s Score. Results are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 4&#x2013;6 mice/group. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01).</p>
</caption>
<graphic xlink:href="fphar-12-633403-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Hypoxia Induces the Interaction between A<sub>2A</sub>R and mGluR5</title>
<p>There are synergistic interactions between A<sub>2A</sub>R, mGluR5, and the dopamine D2 receptor (D2R) in central nervous system (CNS) related diseases (<xref ref-type="bibr" rid="B13">Ferraro et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B12">Fern&#xe1;ndez-Due&#xf1;as et&#x20;al., 2013</xref>). However, whether this relationship exists in the enteric nervous system has yet to be determined. It has been suggested that in micro glial cells, A<sub>2A</sub>R combines with D2R in low glutamate concentration and combines with mGluR5 in high glutamate concentration (<xref ref-type="bibr" rid="B10">Dai et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B4">Beggiato et&#x20;al., 2016</xref>). Therefore, we used high glutamate concentrations as a positive control. We studied the relationship among them under hypoxia in EGCs. When exploring the effect of oxygen concentration, the band corresponding to D2R was coimmunoprecipitated by anti-A<sub>2A</sub>R antibodies, and an A<sub>2A</sub>R band was coimmunoprecipitated by anti-D2R antibodies. Together, these results indicate that A<sub>2A</sub>R and D2R interact in normoxic but not in hypoxic conditions (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). However, an opposite relationship was observed between A<sub>2A</sub>R and mGluR5. As shown in <xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>, the band corresponding to mGluR5 was coimmunoprecipitated by anti-A<sub>2A</sub>R antibodies, and an A<sub>2A</sub>R band was also coimmunoprecipitated by anti-mGluR5 antibodies. These results indicate that A<sub>2A</sub>R and D2R interact in hypoxia but not in normoxia, demonstrating that A<sub>2A</sub>R interacts with D2R under normoxic conditions and interacts with mGluR5 under hypoxic conditions.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The protective effect of A<sub>2A</sub>R on the intestinal epithelial barrier (IEB) is mediated by combining with mGluR5. <bold>(A)</bold> Co-IP of A<sub>2A</sub>R and D2R or mGluR5 in enteric glial cells (EGCs) using an anti-A<sub>2A</sub>R precipitating antibody. <bold>(B)</bold> Interactions between A<sub>2A</sub>R and D2R or mGluR5 in EGCs were confirmed by Co-IP using anti- D2R or anti-mGluR5 precipitating antibodies. <bold>(C</bold>,<bold>D)</bold> EGCs were co-cultured with Caco-2 monolayers for 24&#xa0;h and then treated with MPEP (100&#xa0;&#x3bc;M) and CGS21680 (100&#xa0;nM) for 6&#xa0;h respectively under hypoxia conditions. <bold>(C)</bold> Western blot and <bold>(D)</bold> TER analysis were used to detect the function of IEB. Results are expressed as mean&#x20;&#xb1; SD. (&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01).</p>
</caption>
<graphic xlink:href="fphar-12-633403-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>mGluR5 Inhibition Attenuates the Protective Effect of A<sub>2A</sub>R on the IEB from Hypoxia Induced Damage</title>
<p>To confirm that A<sub>2A</sub>R regulates the IEB via a mGluR5-dependent pathway, we tested the responsiveness of the IEB to 100&#xa0;&#x3bc;M of the MPEP selective mGluR5 antagonist under hypoxia. Western blot analysis of ZO-1 and occludin expression revealed that treatment with MPEP significantly inhibited CGS21680-mediated activation of ZO-1 and occludin expression after hypoxia induced damage (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>). Similar results were observed in TER measurements: CGS21680 pretreatment effectively prevented the decrease of TER from hypoxia stimulation, while, MPEP blocked CGS21680-induced potentiation (454.3&#x20;&#xb1; 15.7&#xa0;&#x3a9;&#xa0;cm<sup>2</sup> vs. 391&#x20;&#xb1; 8.441&#xa0;&#x3a9;&#xa0;cm<sup>2</sup>) (<xref ref-type="fig" rid="F4">Figure&#x20;4D</xref>). Together, these results indicate that the protective effect of A<sub>2A</sub>Ron the IEB after hypoxia stimulation is dependent on mGluR5.</p>
</sec>
<sec id="s3-6">
<title>The PKC&#x3b1; Signaling Pathway Is Required for the Protective Function of A<sub>2A</sub>R on IEB</title>
<p>The PKC&#x3b1; signaling pathway is associated with an A<sub>2A</sub>R&#x2013;mGluR5&#x20;interaction-associated proinflammatory effect (<xref ref-type="bibr" rid="B9">Dai et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B21">Li et&#x20;al., 2017</xref>). Therefore, we next tested whether PKC&#x3b1; is required for A<sub>2A</sub>R-mediated IEB protection. PKC family isoforms can translocate to multiple subcellular localizations in response to hypoxia in different cell lines (<xref ref-type="bibr" rid="B44">Yu et&#x20;al., 2015</xref>). Consistent with this, western blots showed increased PKC&#x3b1; expression in the membrane after hypoxia stimulation in EGCs (<xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>). These results were confirmed by immunocytochemistry analysis showing that PKC&#x3b1; translocates from the cytoplasm to the cell membrane in EGCs after hypoxia stimulation (<xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>). We then used PKC&#x3b1; inhibitor, chelerythrine chloride, to observe whether the protective effect of CGS21680 on IEB was affected. As shown in <xref ref-type="fig" rid="F5">Figure&#x20;5C</xref>, chelerythrine chloride significantly reduced ZO-1 and occludin protein levels in CGS21680-pretreated EGCs. As expected, chelerythrine chloride pretreatment also blocked CGS21680-promoted TER (533&#x20;&#xb1; 24.2&#xa0;&#x3a9;&#xa0;cm<sup>2</sup> vs. 390.9&#x20;&#xb1; 24.14&#xa0;&#x3a9;&#xa0;cm<sup>2</sup>) (<xref ref-type="fig" rid="F5">Figure&#x20;5D</xref>). Together, these results suggest that A<sub>2A</sub>R exerts its protective effects on IEB via the PKC&#x3b1; signaling pathway.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>The protective effect of A<sub>2A</sub>R on IEB is PKC&#x3b1; dependent. PKC&#x3b1; expression was assessed in different enteric glial cells (EGCs) fractions. <bold>(A)</bold> Membrane and cytosol proteins were respectively extracted to detect PKC&#x3b1; change under hypoxia. <bold>(B)</bold> Immunofluorescence was used to visualize PKC&#x3b1; distribution under hypoxia. <bold>(C</bold>,<bold>D)</bold> EGCs were co-cultured with Caco-2 monolayers for 24&#xa0;h, then treated with chelerythrine chloride (10&#xa0;&#x3bc;M) and CGS21680 (100&#xa0;nM) for 6&#xa0;h under hypoxic conditions. <bold>(C)</bold> Western blot and <bold>(D)</bold> TER analysis were used to detect the function of IEB. Results are expressed as mean&#x20;&#xb1; SD. (&#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001).</p>
</caption>
<graphic xlink:href="fphar-12-633403-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Our research has previously demonstrated that EGCs enhance IEB functions under acute intestinal injury (<xref ref-type="bibr" rid="B43">Xiao et&#x20;al., 2014</xref>). In this context, our data provide the first evidence that EGCs protect IEB by activating A<sub>2A</sub>R. The A<sub>2A</sub>R agonist significantly improved the barrier functions of Caco-2 monolayers following exposure to HR stimulation. Moreover, in A<sub>2A</sub>R KO mice, intestinal tissue damage was accelerated, including the structural and mucosal barrier defects, following intestinal I/R. We found that A<sub>2A</sub>R combines with mGluR5 under hypoxic conditions to exert a protective effect on IEB. This data also shows that A<sub>2A</sub>R and mGluR5 combine to activate the PKC&#x3b1;-dependent signaling pathway. Together, these results show that A<sub>2A</sub>R plays a critical role in the barrier protective mechanism of EGCs under acute intestinal hypoxia stimulation.</p>
<p>EGCs are involved in the regulation of IEB function. However, the precise mechanisms by which EGCs function in the regulation of IEB remain unclear. Increasing evidence indicates that EGCs and astrocytes share morphological features and electrophysiological properties and express similar proteins, including GFAP and S100&#x3b2;, leading to the idea that EGCs might share many features of the central nervous system astrocytes (<xref ref-type="bibr" rid="B19">Le Berre-Scoul et&#x20;al., 2017</xref>). The similarities between EGCs and astrocytes indicate that these two glial cell types may regulate barrier functions through common molecular mechanisms (<xref ref-type="bibr" rid="B18">Jiang et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B43">Xiao et&#x20;al., 2014</xref>). It is reported that primary cell cultures of either astrocytes or enteric glia can induce barrier properties across endothelia and epithelia (<xref ref-type="bibr" rid="B33">Savidge et&#x20;al., 2007</xref>). Jiang Set&#x20;al. previously reported that implantation of enteric glia accelerates normal spinal cord vasculature repair processes at the site of injury and promotes functional blood-brain barrier (BBB) induction (<xref ref-type="bibr" rid="B18">Jiang et&#x20;al., 2005</xref>). Additionally, glia promote blood-brain barrier-like properties in peripheral sites including blood-ocular barriers in the eye, the perineurium of peripheral nerves, and the blood myenteric plexus barrier in the gut (<xref ref-type="bibr" rid="B15">Gershon and Bursztajn, 1978</xref>; <xref ref-type="bibr" rid="B33">Savidge et&#x20;al., 2007</xref>). Our previous LPS and hypoxia reperfusion stimulation studies showed that EGCs can effectively alleviate IEB damage (<xref ref-type="bibr" rid="B42">Xiao et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B43">Xiao et&#x20;al., 2014</xref>). Therefore, we explored the mechanism by which EGCs protect the&#x20;IEB.</p>
<p>A<sub>2A</sub>R activation is closely related to a variety of neurological diseases and is an important component of the adenosine signaling pathway (<xref ref-type="bibr" rid="B35">Stone et&#x20;al., 2009</xref>). Recently, many studies have suggested that A<sub>2A</sub>R also plays an important protective role in enteritis (<xref ref-type="bibr" rid="B40">Warren et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B1">Antonioli et&#x20;al., 2018</xref>). However, there is relatively little information about the role of A<sub>2A</sub>R in intestinal IR damage. A<sub>2A</sub>R inactivation can prevent IR by regulating the inflammatory response and excitotoxic cascades in the brain, kidney, lung, and blood vessels (<xref ref-type="bibr" rid="B37">Vincent and Okusa, 2015</xref>; <xref ref-type="bibr" rid="B22">Li et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B27">Mohamed et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B26">Mohamed et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B17">Gui et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B8">Cunha, 2005</xref>). Due to the similarities between the brain and the intestine, we speculate that A<sub>2A</sub>R may also have protective effects on intestinal IR damage. Our data shows that IEB damage is accelerated in A<sub>2A</sub>R KO mice. However, because there are no mice with selective inactivation of EGCs-derived A<sub>2A</sub>R, we cannot comprehensively show that EGCs protect IEB via the A<sub>2A</sub>R pathway. We exposed an <italic>in&#x20;vitro</italic> EGC-Caco-2&#x20;co-culture system to hypoxia treatment to detect the role of A<sub>2A</sub>R in EGCs. Our results show that activation of A<sub>2A</sub>R in EGCs prevents damage to the IEB during hypoxia.</p>
<p>To clarify the mechanism by which A<sub>2A</sub>R influences IEB functions under acute intestinal epithelium hypoxia injury, we explored how A<sub>2A</sub>R works in the brain. Functional A<sub>2A</sub>R-mGluR5 heteromeric complexes have been reported in the central nervous system (<xref ref-type="bibr" rid="B4">Beggiato et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B36">Temido-Ferreira et&#x20;al., 2018</xref>). Beggiato et&#x20;al. found that A<sub>2A</sub>R and mGlu5R interact synergistically to modulate D2R-mediated control of striatopallidal GABA neurons (<xref ref-type="bibr" rid="B4">Beggiato et&#x20;al., 2016</xref>). Additionally, Dai et&#x20;al. reported that A<sub>2A</sub>R-mGluR5 interplay is critical for the proinflammatory effect in bone marrow-derived cells (BMDCs) after acute lung injury (<xref ref-type="bibr" rid="B9">Dai et&#x20;al., 2013</xref>). Consistent with our expectation, we observed that A<sub>2A</sub>R combined with mGluR5 in EGCs suffering from hypoxia.</p>
<p>mGluR5 is a G-protein-coupled receptor that exerts its physiological roles through intracellular chemical-messenger signaling cascades (<xref ref-type="bibr" rid="B31">Power et&#x20;al., 2016</xref>). In general, mGluR5 represents a promising target for studying neuro-protective agents of potential application in neurodegenerative diseases (<xref ref-type="bibr" rid="B21">Li et&#x20;al., 2017</xref>). However, little data exists supporting the function of mGluR5 in the intestine, especially in relation to its role in IEB regulation. In the intestinal mucosa, mGluR5 is only observed in EGCs (<xref ref-type="bibr" rid="B28">Nasser et&#x20;al., 2007</xref>). EGCs are involved in the occurrence of inflammatory bowel disease through c-Fos and ERK1/2 phosphorylation induced by mGluR5 (<xref ref-type="bibr" rid="B28">Nasser et&#x20;al., 2007</xref>). In the present study, we demonstrated that mGluR5 plays a key role in the protection of IEB by A<sub>2A</sub>R. The proinflammatory effect of mGluR5 is not mediated by PKC signaling, but instead uses the PKA pathway (<xref ref-type="bibr" rid="B9">Dai et&#x20;al., 2013</xref>). Giaroni et&#x20;al. reported that the PKC&#x3b1; antagonist significantly inhibits intestinal mucosal injury induced by IR (<xref ref-type="bibr" rid="B16">Giaroni et&#x20;al., 2011</xref>). These studies provide further support for our results that A<sub>2A</sub>R protects the IEB by a PKC&#x3b1; dependent pathway.</p>
<p>Taken together, our results suggest a model for A<sub>2A</sub>R in the maintenance of intestinal barrier function. Upon intestinal hypoxia injury, A<sub>2A</sub>R combines with mGluR5 to protect IEB function via the PKC&#x3b1; pathway in EGCs (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>). Although there are complex interactions between A<sub>2A</sub>R and mGluR5 that remain to be fully understood, our findings are important for a better understanding of the role of EGCs in regulating IEB. Additionally, these findings offer new insight into the clinical use of A<sub>2A</sub>R modulators for IR-induced intestinal injury.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>A proposed model for A<sub>2A</sub>R in the maintenance of intestinal barrier function. Under normoxic conditions, A<sub>2A</sub>R combines with D2R to maintain the normal physiological activities of EGCs through the PKA signaling pathway. Under hypoxic conditions, A<sub>2A</sub>R combines with mGluR5 to protect IEB function via the PKC&#x3b1; pathway in EGCs.</p>
</caption>
<graphic xlink:href="fphar-12-633403-g006.tif"/>
</fig>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Animal Ethics Committee of the Army Medical University.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>LS and XL contributed equally to this work. LS and XL conceived the study and analyzed the data. HG, SC, XF, and CZ performed the research. HY and WX wrote the manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This research was supported by grants from the National&#x20;Natural Science Foundation of China (NSFC 81770524 and NSFC 81470803 to WX), and the Program of Changjiang Scholars and Innovative Research (IRT 13050 to&#x20;HY).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ack>
<p>We thank Professor Yuanguo Zhou for providing the A<sub>2A</sub>R<sup>&#x2212;/&#x2212;</sup>&#x20;mice.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonioli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>El-Tayeb</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pellegrini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fornai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Awwad</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Giustarini</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Anti-inflammatory effect of a novel locally acting A2A receptor agonist in a rat model of oxazolone-induced colitis</article-title>. <source>Purinergic Signal.</source> <volume>14</volume> (<issue>1</issue>), <fpage>27</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/s11302-017-9591-2</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonioli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fornai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Colucci</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ghisu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Blandizzi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Del Tacca</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis</article-title>. <source>Inflamm. Bowel Dis.</source> <volume>12</volume> (<issue>2</issue>), <fpage>117</fpage>&#x2013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1097/01.mib.0000198535.13822.a9</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aube</surname>
<given-names>A.-C.</given-names>
</name>
<name>
<surname>Cabarrocas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Aubert</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Doulay</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption</article-title>. <source>Gut</source> <volume>55</volume> (<issue>5</issue>), <fpage>630</fpage>&#x2013;<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2005.067595</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beggiato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Borelli</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Borroto-Escuela</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Fuxe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Antonelli</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission</article-title>. <source>J.&#x20;Neurochem.</source> <volume>138</volume> (<issue>2</issue>), <fpage>254</fpage>&#x2013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13652</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bush</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Savidge</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Mucke</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice</article-title>. <source>Cell</source> <volume>93</volume> (<issue>2</issue>), <fpage>189</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)81571-8</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cabarrocas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Savidge</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Liblau</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Role of enteric glial cells in inflammatory bowel disease</article-title>. <source>Glia</source> <volume>41</volume> (<issue>1</issue>), <fpage>81</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1002/glia.10169</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheadle</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Costantini</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bansal</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Eliceiri</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Coimbra</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Enteric glia cells attenuate cytomix-induced intestinal epithelial barrier breakdown</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>7</issue>), <fpage>e69042</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0069042</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunha</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade</article-title>. <source>Purinergic Signal.</source> <volume>1</volume> (<issue>2</issue>), <fpage>111</fpage>&#x2013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1007/s11302-005-0649-1</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>S.-S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>Y.-L.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Plasma glutamate-modulated interaction of A2AR and mGluR5 on BMDCs aggravates traumatic brain injury-induced acute lung injury</article-title>. <source>J.&#x20;Exp. Med.</source> <volume>210</volume> (<issue>4</issue>), <fpage>839</fpage>&#x2013;<lpage>851</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20122196</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y. G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury</article-title>. <source>J.&#x20;Neurosci.</source> <volume>30</volume> (<issue>16</issue>), <fpage>5802</fpage>&#x2013;<lpage>5810</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0268-10.2010</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duarte-Ara&#xfa;jo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nascimento</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Alexandrina Tim&#xf3;teo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Magalh&#xe3;es-Cardoso</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Correia-de-S&#xe1;</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A2A and extrajunctional inhibitory A1 receptors</article-title>. <source>Br. J.&#x20;Pharmacol.</source> <volume>141</volume> (<issue>6</issue>), <fpage>925</fpage>&#x2013;<lpage>934</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0705697</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez-Due&#xf1;as</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>G&#xf3;mez-Soler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morat&#xf3;</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>N&#xfa;&#xf1;ez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>T. S.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Dopamine D2&#x20;receptor-mediated modulation of adenosine A2A receptor agonist binding within the A2AR/D2R oligomer framework</article-title>. <source>Neurochem. Int.</source> <volume>63</volume> (<issue>1</issue>), <fpage>42</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2013.04.006</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferraro</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Beggiato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Fuxe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Antonelli</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanganelli</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>A2A/D2 receptor heteromerization in a model of Parkinson&#x2019;s disease. Focus on striatal aminoacidergic signaling</article-title>. <source>Brain Res.</source> <volume>1476</volume>, <fpage>96</fpage>&#x2013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.01.032</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fornai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Antonioli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Colucci</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ghisu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Buccianti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>A1and A2areceptors mediate inhibitory effects of adenosine on the motor activity of human colon</article-title>. <source>Neurogastroenterol. Motil.</source> <volume>21</volume> (<issue>4</issue>), <fpage>451</fpage>&#x2013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2982.2008.01213.x</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gershon</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Bursztajn</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>Properties of the enteric nervous system: limitation of access of intravascular macromolecules to the myenteric plexus and muscularis externa</article-title>. <source>J.&#x20;Comp. Neurol.</source> <volume>180</volume> (<issue>3</issue>), <fpage>467</fpage>&#x2013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1002/cne.901800305</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giaroni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zanetti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Giuliani</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Oldrini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Marchet</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moro</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Protein kinase C modulates NMDA receptors in the myenteric plexus of the Guinea pig ileum during <italic>in&#x20;vitro</italic> ischemia and reperfusion</article-title>. <source>Neurogastroenterol. Motil.</source> <volume>23</volume> (<issue>2</issue>), <fpage>e91</fpage>&#x2013;<lpage>e103</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2982.2010.01644.x</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gui</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.-F.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Adenosine A2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice</article-title>. <source>Brain Res.</source> <volume>1297</volume>, <fpage>185</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.08.050</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Werstiuk</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Rathbone</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Acceleration of blood-brain barrier formation after transplantation of enteric glia into spinal cords of rats</article-title>. <source>Exp. Brain Res.</source> <volume>162</volume> (<issue>1</issue>), <fpage>56</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-004-2119-3</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Berre-Scoul</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chevalier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Oleynikova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cossais</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Talon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Neunlist</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>A novel enteric neuron-glia coculture system reveals the role of glia in neuronal development</article-title>. <source>J.&#x20;Physiol.</source> <volume>595</volume> (<issue>2</issue>), <fpage>583</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1113/jp271989</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases</article-title>. <source>Intest Res.</source> <volume>13</volume> (<issue>1</issue>), <fpage>11</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.5217/ir.2015.13.1.11</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Pu-erh tea protects the nervous system by inhibiting the expression of metabotropic glutamate receptor 5</article-title>. <source>Mol. Neurobiol.</source> <volume>54</volume> (<issue>7</issue>), <fpage>5286</fpage>&#x2013;<lpage>5299</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-0064-3</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Y-J.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>S.-S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Sinomenine protects against lipopolysaccharide-induced acute lung injury in mice via adenosine A(2A) receptor signaling</article-title>. <source>PLoS One</source> <volume>8</volume> (<issue>3</issue>), <fpage>e59257</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0059257</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Aryl hydrocarbon receptor activation maintained the intestinal epithelial barrier function through Notch1 dependent signaling pathway</article-title>. <source>Int. J.&#x20;Mol. Med.</source> <volume>41</volume> (<issue>3</issue>), <fpage>1560</fpage>&#x2013;<lpage>1572</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2017.3341</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.-Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C.-C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>T.-C.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Neutrophil priming by hypoxic preconditioning protects against epithelial barrier damage and enteric bacterial translocation in intestinal ischemia/reperfusion</article-title>. <source>Lab. Invest.</source> <volume>92</volume> (<issue>5</issue>), <fpage>783</fpage>&#x2013;<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2012.11</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mallick</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Winslet</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Seifalian</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Ischemia-reperfusion injury of the intestine and protective strategies against injury</article-title>. <source>Dig. Dis. Sci.</source> <volume>49</volume> (<issue>9</issue>), <fpage>1359</fpage>&#x2013;<lpage>1377</lpage>. <pub-id pub-id-type="doi">10.1023/b:ddas.0000042232.98927.91</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohamed</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Agha</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Abdel-Rahman</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Nassar</surname>
<given-names>N. N.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Role of adenosine A2A receptor in cerebral ischemia reperfusion injury: signaling to phosphorylated extracellular signal-regulated protein kinase (pERK1/2)</article-title>. <source>Neuroscience</source> <volume>314</volume>, <fpage>145</fpage>&#x2013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.11.059</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohamed</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Agha</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Nassar</surname>
<given-names>N. N.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>SCH58261 the selective adenosine A2A receptor blocker modulates ischemia reperfusion injury following bilateral carotid occlusion: role of inflammatory mediators</article-title>. <source>Neurochem. Res.</source> <volume>37</volume> (<issue>3</issue>), <fpage>538</fpage>&#x2013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-011-0640-x</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasser</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Keenan</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>McCafferty</surname>
<given-names>D.-M.</given-names>
</name>
<name>
<surname>Sharkey</surname>
<given-names>K. A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Expression of a functional metabotropic glutamate receptor 5 on enteric glia is altered in states of inflammation</article-title>. <source>Glia</source> <volume>55</volume> (<issue>8</issue>), <fpage>859</fpage>&#x2013;<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20507</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neunlist</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Landeghem</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bourreille</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Savidge</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Neuro-glial crosstalk in inflammatory bowel disease</article-title>. <source>J.&#x20;Intern. Med.</source> <volume>263</volume> (<issue>6</issue>), <fpage>577</fpage>&#x2013;<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2796.2008.01963.x</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neunlist</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Landeghem</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mah&#xe9;</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Derkinderen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>des Varannes</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Rolli-Derkinderen</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease</article-title>. <source>Nat. Rev. Gastroenterol. Hepatol.</source> <volume>10</volume> (<issue>2</issue>), <fpage>90</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2012.221</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Power</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>English</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Empson</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Are Type 1 metabotropic glutamate receptors a viable therapeutic target for the treatment of cerebellar ataxia?</article-title> <source>J.&#x20;Physiol.</source> <volume>594</volume> (<issue>16</issue>), <fpage>4643</fpage>&#x2013;<lpage>4652</lpage>. <pub-id pub-id-type="doi">10.1113/jp271153</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruhl</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Glial cells in the gut</article-title>. <source>Neurogastroenterol. Motil.</source> <volume>17</volume> (<issue>6</issue>), <fpage>777</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2982.2005.00687.x</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savidge</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Sofroniew</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Neunlist</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Starring roles for astroglia in barrier pathologies of gut and brain</article-title>. <source>Lab. Invest.</source> <volume>87</volume> (<issue>8</issue>), <fpage>731</fpage>&#x2013;<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.3700600</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schriemer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sribudiani</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>IJpma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>MacKenzie</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Metzger</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Regulators of gene expression in enteric neural crest cells are putative Hirschsprung disease genes</article-title>. <source>Develop. Biol.</source> <volume>416</volume> (<issue>1</issue>), <fpage>255</fpage>&#x2013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2016.06.004</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stone</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Ceruti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abbracchio</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Adenosine receptors and neurological disease: neuroprotection and neurodegeneration</article-title>. <source>Handb Exp. Pharmacol.</source> (<issue>193</issue>), <fpage>535</fpage>&#x2013;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-540-89615-9_17</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Temido-Ferreira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Batalha</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Marques-Morgado</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Coelho</surname>
<given-names>J.&#x20;E.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors</article-title>. <source>Mol. Psychiatry</source> <volume>25</volume> (<issue>8</issue>), <fpage>1876</fpage>&#x2013;<lpage>1900</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-018-0110-9</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vincent</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Okusa</surname>
<given-names>M. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Adenosine 2A receptors in acute kidney injury</article-title>. <source>Acta Physiol.</source> <volume>214</volume> (<issue>3</issue>), <fpage>303</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1111/apha.12508</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vollmar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Menger</surname>
<given-names>M. D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences</article-title>. <source>Langenbecks Arch. Surg.</source> <volume>396</volume> (<issue>1</issue>), <fpage>13</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1007/s00423-010-0727-x</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>von Boyen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Steinkamp</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The role of enteric glia in gut inflammation</article-title>. <source>Neuron Glia Biol.</source> <volume>6</volume> (<issue>4</issue>), <fpage>231</fpage>&#x2013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1017/s1740925x11000068</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warren</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pawlowski</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Figler</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Rieger</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Effects of adenosine A<sub>2</sub>A receptor activation and alanyl-glutamine in <italic>Clostridium difficile</italic> toxin-induced ileitis in rabbits and cecitis in mice</article-title>. <source>BMC Infect. Dis.</source> <volume>12</volume>, <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-12-13</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Welihinda</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Amento</surname>
<given-names>E. P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias</article-title>. <source>Cell. Signal.</source> <volume>28</volume> (<issue>6</issue>), <fpage>552</fpage>&#x2013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2016.02.010</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>W.-D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.-H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.-S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.-W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The protective effect of enteric glial cells on intestinal epithelial barrier function is enhanced by inhibiting inducible nitric oxide synthase activity under lipopolysaccharide stimulation</article-title>. <source>Mol. Cell. Neurosci.</source> <volume>46</volume> (<issue>2</issue>), <fpage>527</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2010.12.007</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>GDNF is involved in the barrier-inducing effect of enteric glial cells on intestinal epithelial cells under acute ischemia reperfusion stimulation</article-title>. <source>Mol. Neurobiol.</source> <volume>50</volume> (<issue>2</issue>), <fpage>274</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-8730-9</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Hypoxic preconditioning promotes the translocation of protein kinase C &#x3b5; binding with caveolin-3 at cell membrane not mitochondrial in rat heart</article-title>. <source>Cell Cycle</source> <volume>14</volume> (<issue>22</issue>), <fpage>3557</fpage>&#x2013;<lpage>3565</lpage>. <pub-id pub-id-type="doi">10.1080/15384101.2015.1084446</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>F. Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis</article-title>. <source>J.&#x20;Pathol.</source> <volume>222</volume> (<issue>2</issue>), <fpage>213</fpage>&#x2013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1002/path.2749</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>